Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
REVENUES    
Neurometric Information Services $ 28,200 $ 32,000
OPERATING EXPENSES:    
Cost of Neurometric Service revenues 31,400 39,200
Research 55,800 69,700
Product development 87,100 112,500
Sales and marketing 91,500 286,200
General and administrative 461,300 808,700
Total operating expenses 727,100 1,316,300
OPERATING LOSS (698,900) (1,284,300)
OTHER INCOME (EXPENSE):    
Interest income (expense), net (598,400) (1,482,000)
Gain on extinguishment of debt 466,300 0
Financing fees (31,700) (45,300)
Offering costs 0 (6,800)
Gain (Loss) on derivative liabilities (97,600) 232,100
Total other income (expense) (261,400) (1,302,000)
LOSS BEFORE PROVISION FOR INCOME TAXES (960,300) (2,586,300)
Provision for income taxes 800 900
LOSS BEFORE OTHER COMPREHENSIVE INCOME (961,100) (2,587,200)
Other Comprehensive Income (Loss) 0 0
LOSS FROM CONTINUING OPERATIONS (961,100) (2,587,200)
Loss from discontinued operations (12,200) (144,100)
NET LOSS $ (973,300) $ (2,731,300)
BASIC LOSS PER SHARE:    
From continuing operations (in dollars per share) $ (0.47) $ (1.38)
From discontinued operations (in dollars per share) $ (0.01) $ (0.08)
Combined Net Loss (in dollars per share) $ (0.48) $ (1.46)
DILUTED LOSS PER SHARE:    
From continuing operations (in dollars per share) $ (0.47) $ (1.38)
From discontinued operations (in dollars per share) $ (0.01) $ (0.08)
Combined Net Loss forfeiture (in dollars per share) $ (0.48) $ (1.46)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic (in shares) 2,024,619 1,873,583
Diluted (in shares) 2,024,619 1,873,583